{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:34:30Z","timestamp":1794108870406,"version":"4.8.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Amgis Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1038\/s41372-022-01335-3","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T08:12:47Z","timestamp":1645085567000},"page":"1026-1031","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Rates of substance and polysubstance use through universal maternal testing at the time of delivery"],"prefix":"10.1038","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2745-1461","authenticated-orcid":false,"given":"Brittany L.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9477-8619","authenticated-orcid":false,"given":"Eric S.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"McAllister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Marcotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth D. R.","family":"Setchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Megaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine L.","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"John Winhusen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4174-1396","authenticated-orcid":false,"given":"Scott L.","family":"Wexelblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"1335_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12688\/f1000research.7645.1","volume":"5","author":"A Forray","year":"2016","unstructured":"Forray A. Substance use during pregnancy. F1000Research. 2016;5:1\u20139.","journal-title":"F1000Research"},{"key":"1335_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/pr.2011.25","volume":"71","author":"MR Hayatbakhsh","year":"2012","unstructured":"Hayatbakhsh MR, Flenady VJ, Gibbons KS, Kingsbury AM, Hurrion E, Mamun AA, et al. Birth outcomes associated with cannabis use before and during pregnancy. Pediatr Res. 2012;71:215\u20139.","journal-title":"Pediatr Res"},{"key":"1335_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0892-0362(87)90082-1","volume":"9","author":"PA Fried","year":"1987","unstructured":"Fried PA, O\u2019Connell CM. A comparison of the effects of prenatal exposure to tobacco, alcohol, cannabis and caffeine on birth size and subsequent growth. Neurotoxicol Teratol. 1987;9:79\u201385.","journal-title":"Neurotoxicol Teratol"},{"key":"1335_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/AOG.0000000000000052","volume":"123","author":"MW Varner","year":"2014","unstructured":"Varner MW, Silver RM, Hogue CJR, Willinger M, Parker CB, Thorsten VR, et al. Association between stillbirth and illicit drug use and smoking during pregnancy. Obstet Gynecol. 2014;123:113\u201325.","journal-title":"Obstet Gynecol"},{"key":"1335_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2015-009986","volume":"6","author":"JKL Gunn","year":"2016","unstructured":"Gunn JKL, Rosales CB, Center KE, Nu\u00f1ez A, Gibson SJ, Christ C, et al. Prenatal exposure to cannabis and maternal and child health outcomes: A systematic review and meta-analysis. BMJ Open. 2016;6:1\u20138.","journal-title":"BMJ Open"},{"key":"1335_CR6","doi-asserted-by":"crossref","unstructured":"Coleman-Cowger VH, Oga EA, Peters EN, Mark K. Prevalence and associated birth outcomes of co-use of Cannabis and tobacco cigarettes during pregnancy. Neurotoxicol Teratol. 2018;68:84\u201390.","DOI":"10.1016\/j.ntt.2018.06.001"},{"key":"1335_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/pop.2018.0016","volume":"22","author":"ES Hall","year":"2019","unstructured":"Hall ES, Mcallister JM, Wexelblatt SL. Developmental disorders and medical complications among infants with subclinical intrauterine opioid exposures. Popul Health Manag. 2019;22:19\u201324.","journal-title":"Popul Health Manag"},{"key":"1335_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1055\/s-0034-1383419","volume":"75","author":"M Daseking","year":"2015","unstructured":"Daseking M, Petermann F, Tischler T, Waldmann HC. Smoking during pregnancy is a risk factor for executive function deficits in preschool-aged children. Geburtshilfe Frauenheilkd. 2015;75:64\u201371.","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"1335_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/09297049.2015.1092509","volume":"23","author":"E Nygaard","year":"2017","unstructured":"Nygaard E, Slinning K, Moe V, Walhovd KB. Cognitive function of youths born to mothers with opioid and poly-substance abuse problems during pregnancy. Child Neuropsychol. 2017;23:159\u201387.","journal-title":"Child Neuropsychol"},{"key":"1335_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamanetworkopen.2019.7025","volume":"2","author":"SL Yeoh","year":"2019","unstructured":"Yeoh SL, Eastwood J, Wright IM, Morton R, Melhuish E, Ward M, et al. Cognitive and motor outcomes of children with prenatal opioid exposure: a systematic review and meta-analysis. JAMA Netw Open. 2019;2:1\u201314.","journal-title":"JAMA Netw Open"},{"key":"1335_CR11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1542\/hpeds.2018-0227","volume":"9","author":"LA Sanlorenzo","year":"2019","unstructured":"Sanlorenzo LA, Cooper WO, Dudley JA, Stratton S, Maalouf FI, Patrick SW. Increased severity of neonatal abstinence syndrome associated with concomitant antenatal opioid and benzodiazepine exposure. Hosp Pediatr. 2019;9:569\u201375.","journal-title":"Hosp Pediatr"},{"key":"1335_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/ADM.0b013e3182266a3a","volume":"5","author":"EM Wachman","year":"2011","unstructured":"Wachman EM, Newby PK, Vreeland J, Byun J, Bonganzi A, Bauchner H, et al. The relationship between maternal opioid agonists and psychiatric medications on length of hospitalization for neonatal abstinence syndrome. J Addict Med. 2011;5:293\u20139.","journal-title":"J Addict Med"},{"key":"1335_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.drugalcdep.2011.10.003","volume":"122","author":"LM Jansson","year":"2012","unstructured":"Jansson LM, Di Pietro JA, Elko A, Williams EL, Milio L, Velez M. Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: A comparison of fetal neurobehaviors and infant outcomes. Drug Alcohol Depend. 2012;122:213\u20139.","journal-title":"Drug Alcohol Depend"},{"key":"1335_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1360-0443.2012.04038.x","volume":"107","author":"K Kaltenbach","year":"2012","unstructured":"Kaltenbach K, Holbrook AM, Coyle MG, Heil SH, Salisbury AL, Stine SM, et al. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication. Addiction. 2012;107:45\u201352.","journal-title":"Addiction"},{"key":"1335_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.drugalcdep.2017.08.001","volume":"180","author":"LM Jansson","year":"2017","unstructured":"Jansson LM, Velez ML, McConnell K, Spencer N, Tuten M, Jones H, et al. Maternal buprenorphine treatment and infant outcome. Drug Alcohol Depend. 2017;180:56\u201361.","journal-title":"Drug Alcohol Depend"},{"key":"1335_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.drugalcdep.2004.03.012","volume":"75","author":"RE Choo","year":"2004","unstructured":"Choo RE, Huestis MA, Schroeder JR, Shin AS, Jones HE. Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure. Drug Alcohol Depend. 2004;75:253\u201360.","journal-title":"Drug Alcohol Depend"},{"key":"1335_CR17","doi-asserted-by":"publisher","first-page":"h2102","DOI":"10.1136\/bmj.h2102","volume":"350","author":"RJ Desai","year":"2015","unstructured":"Desai RJ, Huybrechts KF, Hernandez-Diaz S, Mogun H, Patorno E, Kaltenbach K, et al. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. BMJ. 2015;350:h2102.","journal-title":"BMJ"},{"key":"1335_CR18","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jpeds.2014.10.004","volume":"166","author":"SL Wexelblatt","year":"2015","unstructured":"Wexelblatt SL, Ward LP, Torok K, Tisdale E, Meinzen-derr JK, Greenberg JM. Universal maternal drug testing in a high-prevalence region of prescription opiate abuse. J Pediatr. 2015;166:582\u20136.","journal-title":"J Pediatr"},{"key":"1335_CR19","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/jp.2016.100","volume":"36","author":"ES Hall","year":"2016","unstructured":"Hall ES, Wexelblatt SL, Greenberg JM. Self-reported and laboratory evaluation of late pregnancy nicotine exposure and drugs of abuse. J Perinatol. 2016;36:814\u20138.","journal-title":"J Perinatol"},{"key":"1335_CR20","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1038\/s41372-021-01045-2","volume":"41","author":"ES Hall","year":"2021","unstructured":"Hall ES, Mcallister JM, Kelly EA, Setchell KD, Megaraj V, Jimenez KL, et al. Regional comparison of self-reported late pregnancy cigarette smoking to mass spectrometry analysis. J Perinatol. 2021;41:2417\u201323. https:\/\/doi.org\/10.1038\/s41372-021-01045-2.","journal-title":"J Perinatol"},{"key":"1335_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.whi.2010.02.003","volume":"20","author":"SCM Roberts","year":"2010","unstructured":"Roberts SCM, Nuru-Jeter A. Women\u2019s perspectives on screening for alcohol and drug use in prenatal care. Women\u2019s Heal Issues. 2010;20:193\u2013200.","journal-title":"Women\u2019s Heal Issues"},{"key":"1335_CR22","doi-asserted-by":"publisher","unstructured":"Stone R. Pregnant women and substance use: fear, stigma, and barriers to care. Heal Justice 2015;3:1\u201315. https:\/\/doi.org\/10.1186\/s40352-015-0015-5.","DOI":"10.1186\/s40352-015-0015-5"},{"key":"1335_CR23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1089\/jwh.2020.8875","volume":"30","author":"J Campbell","year":"2021","unstructured":"Campbell J, Matoff-Stepp S, Velez ML, Cox HH, Laughon K. Pregnancy-associated deaths from homicide, suicide, and drug overdose: review of research and the intersection with intimate partner violence. J Women\u2019s Heal. 2021;30:236\u201344.","journal-title":"J Women\u2019s Heal"},{"key":"1335_CR24","doi-asserted-by":"publisher","first-page":"489.e1","DOI":"10.1016\/j.ajog.2019.05.045","volume":"221","author":"S Goldman-Mellor","year":"2019","unstructured":"Goldman-Mellor S, Margerison CE. Maternal drug-related death and suicide are leading causes of postpartum death in California. Am J Obstet Gynecol. 2019;221:489.e1\u2013489.","journal-title":"Am J Obstet Gynecol"},{"key":"1335_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10995-010-0594-7","volume":"15","author":"SCM Roberts","year":"2011","unstructured":"Roberts SCM, Pies C. Complex calculations: How drug use during pregnancy becomes a barrier to prenatal care. Matern Child Health J. 2011;15:333\u201341.","journal-title":"Matern Child Health J"},{"key":"1335_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.forsciint.2014.04.042","volume":"241","author":"ML Smith","year":"2014","unstructured":"Smith ML, Nichols DC, Underwood P, Fuller Z, Moser MA, LoDico C, et al. Morphine and codeine concentrations in human urine following controlled poppy seeds administration of known opiate content. Forensic Sci Int. 2014;241:87\u201390.","journal-title":"Forensic Sci Int"},{"key":"1335_CR27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/jat\/27.7.449","volume":"27","author":"TP Rohrig","year":"2003","unstructured":"Rohrig TP, Moore C. The determination of morphine in urine and oral fluid following ingestion of poppy seeds. J Anal Toxicol. 2003;27:449\u201352.","journal-title":"J Anal Toxicol"},{"key":"1335_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.11613\/BM.2013.018","volume":"23","author":"ML Mchugh","year":"2013","unstructured":"Mchugh ML. The Chi-square test of independence Lessons in biostatistics. Biochem Med. 2013;23:143\u20139.","journal-title":"Biochem Med"},{"key":"1335_CR29","doi-asserted-by":"crossref","unstructured":"Rothman K. No adjustments are needed for multiple comparisons. Epidemiology 1990;Jan:43\u20136.","DOI":"10.1097\/00001648-199001000-00010"},{"key":"1335_CR30","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/00031305.1990.10475712","volume":"44","author":"D Saville","year":"1990","unstructured":"Saville D. Multiple comparison procedures: the practical solution. Am Stat. 1990;44:174\u201380.","journal-title":"Am Stat"},{"key":"1335_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/jama.2019.7982","volume":"322","author":"ND Volkow","year":"2019","unstructured":"Volkow ND, Han B, Compton WM, McCance-Katz EF. Self-reported medical and nonmedical cannabis use among pregnant women in the United States. JAMA - J Am Med Assoc. 2019;322:167\u20139.","journal-title":"JAMA - J Am Med Assoc"},{"key":"1335_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jpeds.2018.02.005","volume":"197","author":"TL Crume","year":"2018","unstructured":"Crume TL, Juhl AL, Brooks-Russell A, Hall KE, Wymore E, Borgelt LM. Cannabis use during the perinatal period in a state with legalized recreational and medical marijuana: the association between maternal characteristics, breastfeeding patterns, and neonatal outcomes. J Pediatr. 2018;197:90\u201396.","journal-title":"J Pediatr"},{"key":"1335_CR33","doi-asserted-by":"publisher","first-page":"201.e1","DOI":"10.1016\/j.ajog.2015.03.021","volume":"213","author":"JY Ko","year":"2015","unstructured":"Ko JY, Farr SL, Tong VT, Creanga AA, Callaghan WM. Prevalence and patterns of marijuana use among pregnant and nonpregnant women of reproductive age. Am J Obstet Gynecol. 2015;213:201.e1\u2013201.e10.","journal-title":"Am J Obstet Gynecol"},{"key":"1335_CR34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1001\/jama.2019.8734","volume":"322","author":"DJ Corsi","year":"2019","unstructured":"Corsi DJ, Walsh L, Weiss D, Hsu H, El-Chaar D, Hawken S, et al. Association between self-reported prenatal cannabis use and maternal, perinatal, and neonatal outcomes. JAMA - J Am Med Assoc. 2019;322:145\u201352.","journal-title":"JAMA - J Am Med Assoc"},{"key":"1335_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ntt.2016.08.003","volume":"58","author":"KA Richardson","year":"2016","unstructured":"Richardson KA, Hester AK, McLemore GL. Prenatal cannabis exposure - The \u201cfirst hit\u201d to the endocannabinoid system. Neurotoxicol Teratol. 2016;58:5\u201314.","journal-title":"Neurotoxicol Teratol"},{"key":"1335_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12978-020-0880-9","volume":"17","author":"C Roncero","year":"2020","unstructured":"Roncero C, Valriberas-Herrero I, Mezzatesta-Gava M, Villegas JL, Aguilar L, Grau-L\u00f3pez L. Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review. Reprod Health. 2020;17:1\u20139.","journal-title":"Reprod Health"},{"key":"1335_CR37","doi-asserted-by":"crossref","unstructured":"Hall ES, Wexelblatt SL, Greenberg JM. Surveillance of intrauterine opioid exposures. 2018;21:486\u201392.","DOI":"10.1089\/pop.2017.0184"},{"key":"1335_CR38","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jpeds.2020.03.052","volume":"222","author":"Z Percy","year":"2017","unstructured":"Percy Z, Brokamp C, Mcallister JM, Ryan P, Wexelblatt SL, Hall ES. Subclinical and overt newborn opioid exposure: prevalence and first-year healthcare utilization. J Pediatr. 2017;222:52\u201358.","journal-title":"J Pediatr"},{"key":"1335_CR39","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ajog.2007.10.780","volume":"198","author":"A Azadi","year":"2008","unstructured":"Azadi A, Dildy GA. Universal screening for substance abuse at the time of parturition. Am J Obstet Gynecol. 2008;198:30\u201332.","journal-title":"Am J Obstet Gynecol"},{"key":"1335_CR40","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.drugalcdep.2017.08.031","volume":"180","author":"WS John","year":"2017","unstructured":"John WS, Wu L-T. Trends and correlates of cocaine use and cocaine use disorder in the United States from 2011 to 2015. Drug Alcohol Depend. 2017;180:376\u201384.","journal-title":"Drug Alcohol Depend"},{"key":"1335_CR41","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10995-005-0052-0","volume":"10","author":"AM Arria","year":"2006","unstructured":"Arria AM, Derauf C, LaGasse LL, Grant P, Shah R, Smith L, et al. Methamphetamine and other substance use during pregnancy: Preliminary estimates from the infant development, environment, and lifestyle (IDEAL) study. Matern Child Health J. 2006;10:293\u2013302.","journal-title":"Matern Child Health J"},{"key":"1335_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/ADM.0000000000000101","volume":"9","author":"TE Wright","year":"2015","unstructured":"Wright TE, Schuetter R, Tellei J, Sauvage L. Methamphetamines and pregnancy outcomes. J Addict Med. 2015;9:111\u20137.","journal-title":"J Addict Med"},{"key":"1335_CR43","doi-asserted-by":"crossref","unstructured":"Yossuck P, Tacker DH. Drug positivity findings from a universal umbilical cord tissue drug analysis program in appalachia. J Appl Lab Med. 2020;6:285\u201397.","DOI":"10.1093\/jalm\/jfaa196"},{"key":"1335_CR44","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1093\/ntr\/nts274","volume":"15","author":"MS Chisolm","year":"2013","unstructured":"Chisolm MS, Fitzsimons H, Leoutsakos JMS, Acquavita SP, Heil SH, Wilson-Murphy M, et al. A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine. Nicotine Tob Res. 2013;15:1297\u2013304.","journal-title":"Nicotine Tob Res"},{"key":"1335_CR45","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1080\/00952990903125235","volume":"35","author":"HE Jones","year":"2009","unstructured":"Jones HE, Heil SH, O\u2019Grady KE, Martin PR, Kaltenbach K, Coyle MG, et al. Smoking in pregnant women screened for an opioid agonist medication study compared to related pregnant and non-pregnant patient samples. Am J Drug Alcohol Abus. 2009;35:375\u201380.","journal-title":"Am J Drug Alcohol Abus"},{"key":"1335_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1360-0443.2012.04035.x","volume":"107","author":"HE Jones","year":"2012","unstructured":"Jones HE, Heil SH, Baewert A, Arria AM, Kaltenbach K, Martin PR, et al. Buprenorphine treatment of opioid-dependent pregnant women: A comprehensive review. Addiction. 2012;107:5\u201327.","journal-title":"Addiction"},{"key":"1335_CR47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/14767050412331283913","volume":"16","author":"R Maupin","year":"2004","unstructured":"Maupin R, Lyman R, Fatsis J, Prystowiski E, Nguyen A, Wright C, et al. Characteristics of women who deliver with no prenatal care. J Matern Neonatal Med. 2004;16:45\u201350.","journal-title":"J Matern Neonatal Med"},{"key":"1335_CR48","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.chiabu.2008.05.009","volume":"33","author":"SH Friedman","year":"2009","unstructured":"Friedman SH, Heneghan A, Rosenthal M. Disposition and health outcomes among infants born to mothers with no prenatal care. Child Abus Negl. 2009;33:116\u201322.","journal-title":"Child Abus Negl"},{"key":"1335_CR49","first-page":"503","volume":"174","author":"EG Hulsey","year":"2020","unstructured":"Hulsey EG, Li Y, Hacker K, Williams K, Collins K, Dalton E. Potential emerging risks among children following parental opioid-related overdose death. JAMA - J Am Med Assoc. 2020;174:503\u20134.","journal-title":"JAMA - J Am Med Assoc"},{"key":"1335_CR50","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11414-020-09712-6","volume":"47","author":"CD Morris","year":"2020","unstructured":"Morris CD, Garver-Apgar CE. Nicotine and opioids: a call for co-treatment as the standard of care. J Behav Heal Serv Res. 2020;47:601\u201313.","journal-title":"J Behav Heal Serv Res"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41372-022-01335-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-022-01335-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-022-01335-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T16:41:32Z","timestamp":1726677692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-022-01335-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1335"],"URL":"https:\/\/doi.org\/10.1038\/s41372-022-01335-3","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,17]]},"assertion":[{"value":"11 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We disclose that financial support for this work was provided by a grant from Chiesi Farmaceutici and a gift from Amgis Foundation, Inc. However, neither organization participated in study design, data collection, data analysis and interpretation, manuscript preparation, or the decision for manuscript submission. SLW has been a member of the speaker bureau for Abbott Nutrition in the past 2 years.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}